Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 71.27% is 14% above its 2-year average of 62.54%, near the high end of its 2-year range (49.96%–72.97%).
1.79% above its 12-month average of 70.02%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 70.45%.
GROSS MARGIN
71.27%
GROSS MARGIN AVG TTM
70.02%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.79%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 644 covered companies
CURRENT VS SECTOR MEDIAN
+72.96%
vs the sector median at left
Market Cap
$4.64B
Gross Margin
18.17%
TTM Avg
19.16%
3Y Avg
20.78%
5Y Avg
21.38%
Market Cap
$4.65B
Gross Margin
33.56%
TTM Avg
32.27%
3Y Avg
30.18%
5Y Avg
31.09%
Market Cap
$4.68B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.81B
Gross Margin
96.01%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
83.33%
Market Cap
$4.84B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.45B
Gross Margin
75.44%
TTM Avg
66.98%
3Y Avg
64.58%
5Y Avg
67.25%
Market Cap
$4.41B
Gross Margin
83.86%
TTM Avg
80.36%
3Y Avg
82.01%
5Y Avg
82.83%
Market Cap
$4.87B
Gross Margin
81.70%
TTM Avg
78.24%
3Y Avg
78.79%
5Y Avg
67.54%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BillionToOne, Inc. (BLLN) | $4.62B | 71.27% | 70.02% | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 18.17% | 19.16% | 20.78% | 21.38% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.65B | 33.56% | 32.27% | 30.18% | 31.09% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.68B | 0.00% | 0.00% | 0.00% | 0.00% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.81B | 96.01% | 100.00% | 100.00% | 83.33% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | 0.00% | 0.00% | 0.00% | 0.00% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | 75.44% | 66.98% | 64.58% | 67.25% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.41B | 83.86% | 80.36% | 82.01% | 82.83% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.87B | 81.70% | 78.24% | 78.79% | 67.54% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.38B | 80.08% | 75.94% | 72.82% | 72.82% |
Gross Margin
71.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 70.45% |
| 2026-03-31 | 72.97% |
| 2025-12-31 | 71.42% |
| 2025-09-30 | 69.94% |
| 2025-06-30 | 65.29% |
| 2025-03-31 | 64.40% |
| 2024-12-31 | 57.06% |
| 2024-09-30 | 52.62% |
| 2024-06-30 | 51.25% |
| 2024-03-31 | 49.96% |
